Shopping Cart
- Remove All
- Your shopping cart is currently empty
Dornidazole (PR-000350, PR-350, RP-343, PR-69) is an effective radiosensitizer for hypoxic cells with the potential for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,420 | 6-8 weeks | |
50 mg | $3,180 | 6-8 weeks | |
100 mg | $4,300 | 6-8 weeks |
Description | Dornidazole (PR-000350, PR-350, RP-343, PR-69) is an effective radiosensitizer for hypoxic cells with the potential for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. |
Alias | RP-343, PR-350, PR350, PR-000350, PR000350 |
Molecular Weight | 247.21 |
Formula | C8H13N3O6 |
Cas No. | 161903-10-2 |
Relative Density. | 1.62 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.